CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
CareDx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$67.08+3.08 (+4.81%)
Close on Oct 19, 2026
- Market cap
- $3.58B
- P/E (TTM)
- 32.4
- Dividend yield
- –
CareDx, Inc. balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- 23.6%
- Net margin
- 24.2%
- Return on equity, FY2025
- -6.3%
Financial strength
- Current ratio
- 4.58
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 398.8%
Valuation
- P/E ratio
- 32.4
- Price to sales
- 7.82
- Price to book
- 8.42
- Dividend yield
- –